NCIt definition : A liposome-encapsulated peptide vaccine consisting of a synthetic peptide derived
from the mucin 1 (MUC-1) antigen with potential antineoplastic activity. Upon vaccination,
MUC-1 peptide vaccine may stimulate the host immune system to mount a cytotoxic T
lymphocyte (CTL) response against MUC-1-expressing tumor cells, resulting in growth
inhibition. MUC-1 antigen is a high-molecular-weight transmembrane glycoprotein that
is overexpressed on the cell surfaces of many epithelial tumor cells as well as on
the cell surfaces of some B-cell lymphoma cells and multiple myeloma cells.;
UNII : Q7Y026G2CX;
CAS number : 221214-84-2; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 221214-84-2
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;